Skip to main content
. 2021 Feb 1;12:620705. doi: 10.3389/fgene.2021.620705

TABLE 2.

Key drugs that had potential therapeutic effects on SARC patients with lower immune or stromal scores.

Drug p value FDR
Immune score based
trichostatin A_MCF7 2.67E-38 9.57E-35
trichostatin A_PC3 8.45E-28 1.51E-24
vorinostat_MCF7 1.38E-05 0.016
Stromal score based
trichostatin A_MCF7 8.49E-39 3.04E-35
trichostatin A_PC3 2.80E-31 5.03E-28
vorinostat_MCF7 4.93E-05 0.059